GR

Goutam Roy

Active Director Director DIN 09746946
DIN 09746946 First appointment Sep 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Goutam Roy

Data last updated:

Goutam Roy is a Director at Bioswin Pharmacy Private Limited (since 2022) and Director at Redivivus Nursing Home Private Limited (since 2022). The companies operate in Pharma and Healthcare.

DIN 09746946
Primary Designation Director
Industry Pharma
First Appointment 26 Sep 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bioswin Pharmacy Private Limited U51909WB2022PTC257524
Director28 Sep 20222022Active
Director26 Sep 20222022Active

Directorship timeline

Open interactive timeline →
Bioswin Pharmacy Private Limited
Redivivus Nursing Home Private Limited
Premium access

Shareholding and investment profile for Goutam Roy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Goutam Roy

Goutam Roy currently holds 2 directorships: Bioswin Pharmacy Private Limited (Director, since 28 Sep 2022); Redivivus Nursing Home Private Limited (Director, since 26 Sep 2022).

Goutam Roy was first appointed on 26 Sep 2022 as Director at Redivivus Nursing Home Private Limited.

The current boards of Goutam Roy's companies include Payel Adhikary (Bioswin Pharmacy Private Limited), Sanjay Roy (Bioswin Pharmacy Private Limited), Sharmistha Roy (Bioswin Pharmacy Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available